Bathi saben saham sajrone rolas wulan pungkasan: Processa Pharma (PCSA)

PCSA (Processa Pharma) - tandha merek perusahaan

Outsourcing development and testing to external contractors creates operational dependency, and the rolling annual earnings per share chart on GURU.Markets is available for analysis, where -5.62 serves as the current metric level. A stable staff of oncologists and the potential of the high-margin PCS platform upon FDA approval allow Processa Pharmaceuticals (PCSA) to effectively scale its business in the breast cancer treatment sector.

PCSA (Processa Pharma) riwayat Bathi resik saben saham sajrone 12 wulan pungkasan saka 04.07.2022 nganti 10.11.2026

Rincian analitis perusahaan Processa Pharmaceuticals Inc. (PCSA)

- rega saham lan target rega konsensus:
Rega saham Processa Pharma|PCSA - Prakiraan konsensus analis
- indikator kapitalisasi bursa perusahaan:
Nilai pasar Processa Pharmaceuticals, Inc.|PCSA - Nilai Bisnis
- data nilai buku modal saham:
Nilai Buku saben Saham Processa Pharmaceuticals|PCSA - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku processapharmaceuticals.com|PCSA - Aset Perusahaan
- indikator beban utang lan likuiditas:
Utang marang Ekuitas Processa Pharmaceuticals|PCSA - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Processa Pharma|PCSA - Gunggung tanggungan utang perusahaan|Rasio utang marang kapitalisasi buku Processa Pharmaceuticals, Inc.|PCSA - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Processa Pharmaceuticals|Rasio cepet processapharmaceuticals.com
- indikator pendapatan resik lan kelipatan nilai:
PCSA - Penghasilan resik|Proyeksi bathi mangsa ngarep Processa Pharmaceuticals|PCSA - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep Processa Pharma|PCSA - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Processa Pharmaceuticals, Inc.|PCSA - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Processa Pharmaceuticals|PCSA - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan processapharmaceuticals.com|PCSA - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Processa Pharmaceuticals
Ringkesan analisis perusahaan:PCSA - processapharmaceuticals.com
Produk seri Processa Pharma

Annual net earnings per share measure the actual portion of income attributable to a single security. This indicator separates actual business efficiency from market hype. By analyzing the 12-month EPS history, an investor can see the objective dynamics of capitalization. For Processa Pharmaceuticals (PCSA), this trend reflects the development cost of the CAP7 platform. Growth in this metric would confirm the successful scaling of the oncology pipeline.

Perusahaan pesaing

Olema Pharmaceuticals - Bathi resik saben saham (EPS TTM)|PBYI - Bathi resik saben saham (EPS TTM)|Greenwich LifeSciences, Inc. (GLSI) - Bathi saben saham sajrone rolas wulan pungkasan|Bathi saben saham sajrone 12 wulan pungkasan ZNTL|MGNX (MacroGenics Corp) - Bathi resik saben saham (EPS TTM)|Bathi resik saben saham sajrone 12 wulan pungkasan Cytori Therapeutics (PSTV)|Bathi resik saben saham (EPS TTM) EGRX